Basic fibroblast growth factor inhibits ventricular remodeling in Dahl salt-sensitive hypertensive rats

Journal of Hypertension

Volumn 26, Issue 12, 2008, Pages 2436-2444

  Suzuki, Takeya ^a   Akasaka, Yoshikiyo ^b   Namiki, Atsushi ^a   Ito, Kinji ^b   Ishikawa, Yukio ^b   Yamazaki, Junichi ^a   Ishii, Toshiharu ^b  

^a TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^b TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Basic fibroblast growth factor; Heart failure; Hypertension; Myofibroblasts; Remodeling

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BASIC FIBROBLAST GROWTH FACTOR; GELATINASE B; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; TRANSFORMING GROWTH FACTOR BETA1; ACTIN; FIBROBLAST GROWTH FACTOR 2; SMOOTH MUSCLE ACTIN, RAT; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; HEART FAILURE; HEART HEMODYNAMICS; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SINGLE DRUG DOSE; SYSTOLE; ANIMAL; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; DAHL SALT SENSITIVE RAT; DISEASE MODEL; DOSE RESPONSE; FIBROSIS; HEART VENTRICLE; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ACTINS; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLAST GROWTH FACTOR 2; FIBROSIS; HEART VENTRICLES; HYPERTENSION; MALE; MATRIX METALLOPROTEINASE 9; NEOVASCULARIZATION, PHYSIOLOGIC; PROCOLLAGEN-PROLINE DIOXYGENASE; RATS; RATS, INBRED DAHL; TRANSFORMING GROWTH FACTOR BETA1; VENTRICULAR REMODELING;

EID: 59849087928     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328312c889     Document Type: Article

References (40)

1. Harada K, Grossman W, Friedman M, Edelman ER, Prasad PV, Keighley CS, et al. Basic ?broblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest 1994; 94:623-630.
2. Lopez JJ, Edelman ER, Stamler A, Hibberd MG, Prasad P, Caputo RP, et al. Basic ?broblast growth factor in a porcine model of chronic myocardial ischemia: a comparison of angiographic, echocardiographic and coronary ?ow parameters. J Pharmacol Exp Ther 1997; 282:385-390.
3. Laham RJ, Rezaee M, Post M, Novicki D, Sellke FW, Pearlman JD, et al. Intrapericardial delivery of ?broblast growth factor-2 induces neovascularization in a porcine model of chronic myocardial ischemia. J Pharmacol Exp Ther 2000; 292:795-802.
4. Yajima S, Ishikawa M, Kubota T, Moroi M, Sugi K, Namiki A. Intramyocardial injection of ?broblast growth factor-2 plus heparin suppresses cardiac failure progression in rats with hypertensive heart disease. Int Heart J 2005; 46:289-301.
5. Drazner MH. The transition from hypertrophy to failure: how certain are we? Circulation 2005; 112:936-938.
6. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 1999; 79:215-262.
7. Boluyt MO, Bing OH. Matrix gene expression and decompensated heart failure: the aged SHR model. Cardiovasc Res 2000; 46:239-249.
8. Kim HE, Dalal SS, Young E, Legato MJ, Weisfeldt ML, D'Armiento J. Disruption of the myocardial extracellular matrix leads to cardiac dysfunction. J Clin Invest 2000; 106:857-866.
9. Woodiwiss AJ, TsotetsiOJ, Sprott S, Lancaster EJ,Mela T, Chung ES, et al. Reduction in myocardial collagen cross-linking parallels left ventricular dilatation in rat models of systolic chamber dysfunction. Circulation 2001; 103:155-160.
10. Fielitz J, Philipp S, Herda LR, Schuch E, Pilz B, Schubert C, et al. Inhibition of prolyl 4-hydroxylase prevents left ventricular remodelling in rats with thoracic aortic banding. Eur J Heart Fail 2007; 9:336-342.
11. Li YY, McTiernan CF, Feldman AM. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc Res 2000; 46:214-224.
12. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat ML, Gabbiani G. The myo?broblast: one function, multiple origins. Am J Pathol 2007; 170:1807-1816.
13. Khouw IM, vanWachem PB, Plantinga JA, Vujaskovic Z,WissinkMJ, de Leij LF, et al. TGF-beta and bFGF affect the differentiation of proliferating porcine ?broblasts into myo?broblasts in vitro. Biomaterials 1999; 20:1815-1822.
14. Maltseva O, Folger P, Zekaria D, Petridou S, Masur SK. Fibroblast growth factor reversal of the corneal myo?broblast phenotype. Invest Ophthalmol Vis Sci 2001; 42:2490-2495.
15. Akasaka Y, Ono I, Yamashita T, Jimbow K, Ishii T. Basic ?broblast growth factor promotes apoptosis and suppresses granulation tissue formation in acute incisional wounds. J Pathol 2004; 203:710-720.
16. Greenberg RS, Bernstein AM, Benezra M, Gelman IH, Taliana L, Masur SK. FAK-dependent regulation of my of broblast differentiation. FASEB J 2006; 20:1006-1008.
17. Slavin J. Fibroblast growth factors: at the heart of angiogenesis. Cell Biol Int 1995; 19:431-444.
18. Rosenberg RD, Shworak NW, Liu J, Schwartz JJ, Zhang L. Heparan sulfate proteoglycans of the cardiovascular system. Speci?c structures emerge but how is synthesis regulated? J Clin Invest 1997; 99:2062-2070.
19. Vlodavsky I, Fuks Z, Ishai-Michaeli R, Bashkin P, Levi E, Korner G, et al. Extracellular matrix-resident basic ?broblast growth factor: implication for the control of angiogenesis. J Cell Biochem 1991; 45:167-176.
20. Kawasuji M, Nagamine H, Ikeda M, Sakakibara N, Takemura H, Fujii S, et al. Therapeutic angiogenesis with intramyocardial administration of basic ?broblast growth factor. Ann Thorac Surg 2000; 69:1155-1161.
21. Yang J, Dai C, Liu Y. Hepatocyte growth factor gene therapy and angiotensin II blockade synergistically attenuate renal interstitial ?brosis in mice. J Am Soc Nephrol 2002; 13:2464-2477.
22. Zheng W, Weiss RM, Wang X, Zhou R, Arlen AM, Lei L, et al. DITPA stimulates arteriolar growth and modi?es myocardial postinfarction remodeling. Am J Physiol Heart Circ Physiol 2004; 286:H1994-H2000.
23. Inoko M, Kihara Y, Morii I, Fujiwara H, Sasayama S. Transition from compensatory hypertrophy to dilated, failing left ventricles in Dahl salt- sensitive rats. Am J Physiol 1994; 267:H2471-H2482.
24. Sun Y, Weber KT. Infarct scar: a dynamic tissue. Cardiovasc Res 2000; 46:250-256.
25. Petrov VV, Fagard RH, Lijnen PJ. Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac ?broblasts to myo?broblasts. Hypertension 2002; 39:258-263.
26. Desmoulière A, Chaponnier C, Gabbiani G. Tissue repair, contraction, and the myo?broblast. Wound Repair Regen 2005; 13:7-12.
27. Nwogu JI, Geenen D, Bean M, Brenner MC, Huang X, Buttrick PM. Inhibition of collagen synthesis with prolyl 4-hydroxylase inhibitor improves left ventricular function and alters the pattern of left ventricular dilatation after myocardial infarction. Circulation 2001; 104:2216-2221.
28. Philipp S, Jürgensen JS, Fielitz J, BernhardtWM,Weidemann A, Schiche A, et al. Stabilization of hypoxia inducible factor rather than modulation of collagen metabolism improves cardiac function after acute myocardial infarction in rats. Eur J Heart Fail 2006; 8:347-354.
29. Losordo DW, Vale PR, Symes JF, Dunnington CH, Esakof DD, Maysky M, et al. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998; 98:2800-2804.
30. Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, et al. Salvage of infarcted myocardium by angiogenic action of basic ?broblast growth factor. Science 1992; 257:1401-1403.
31. Liu Y, Sun L, Huan Y, Zhao H, Deng J. Effects of basic ?broblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analysis with dobutamine cardiovascular magnetic resonance tagging. Eur J Cardiothorac Surg 2006; 30:103-107.
32. Iwanaga Y, Kihara Y, Hasegawa K, Inagaki K, Yoneda T, Kaburagi S, et al. Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats. Circulation 1998; 98:2065-2073.
33. Tsuboi R, Rifkin DB. Recombinant basic ?broblast growth factor stimulates wound healing in healing-impaired db/db mice. J Exp Med 1990; 172:245-251.
34. Flaumenhaft R, Moscatelli D, Saksela O, Rifkin DB. Role of extracellular matrix in the action of basic ?broblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis. J Cell Physiol 1989; 140:75-81.
35. Sakata Y, Yamamoto K, Mano T, Nishikawa N, Yoshida J, Hori M, et al. Activation of matrix metalloproteinases precedes left ventricular remodeling in hypertensive heart failure rats: its inhibition as a primary effect of angiotensin-converting enzyme inhibitor. Circulation 2004; 109:2143- 2149.
36. Ban? C, Cavalca V, Veglia F, Brioschi M, Barcella S, Mussoni L, et al. Neurohormonal activation is associated with increased levels of plasma matrix metalloproteinase-2 in human heart failure. Eur Heart J 2005; 26:481-488.
37. Wagner DR, Delagardelle C, Ernens I, Rouy D, Vaillant M, Beissel J. Matrix metalloproteinase-9 is a marker of heart failure after acute myocardial infarction. J Card Fail 2006; 12:66-72.
38. Brown RD, Jones GM, Laird RE, Hudson P, Long CS. Cytokines regulate matrix metalloproteinases and migration in cardiac ?broblasts. Biochem Biophys Res Commun 2007; 362:200-205.
39. Aharinejad S, Krenn K, Paulus P, Schäfer R, Zuckermann A, Grimm M, et al. Differential role of TGF-beta1/bFGF and ET-1 in graft ?brosis in heart failure patients. Am J Transplant 2005; 5:2185-2192.
40. Silverio-Ruiz KG, Martinez AE, Garlet GP, Barbosa CF, Silva JS, Cicarelli RM, et al. Opposite effects of bFGF and TGF-beta on collagen metabolism by human periodontal ligament ?broblasts. Cytokine 2007; 39:130-137